Led · Equity · Jul 2026

Heroyam operates as a social employment agency that matches newcomers with job opportunities in the Netherlands, emphasizing a humane and personal approach. The company began in 2022 by guiding Ukrainian refugees into employment and expanded in 2023 to assist all newcomers across the country. Co-founders Hans Drijver and Bart Dikkeschei lead the firm and emphasize that tapping unused talent addresses both social needs and business labour shortages. Heroyam aims to help more newcomers secure sustainable employment and to alleviate workforce shortages in the coming years. Financially, the company recently secured just over €1 million in strategic investments from Shaping Impact and Rabobank to accelerate its growth. The firm positions social impact and economic value as mutually reinforcing in its operational model.

Led · Debt Financing · Apr 2026

Elevate develops and operates large-scale battery energy storage and solar projects to provide reliable, dispatchable capacity and support growing electricity demand. Its portfolio includes the recently acquired Prospect Power Storage project (150 MW/600 MWh), currently under construction and scheduled to begin operations in mid‑2026. Elevate was also selected by the New Jersey Board of Public Utilities for the 150 MW/600 MWh Garden State Reliability (Two Rivers Storage) project at the Bergen Generating Station. The company pursues equipment financing and supplier finance solutions to improve working capital, supply chain resilience, and project execution speed. Elevate positions its projects to serve high-demand customers such as data centers and to increase grid resilience and clean energy utilization. The company is a portfolio company of ArcLight Capital Partners.

Participated · Equity · Jan 2026

Founded in 2013, Dealroom operates a data and analytics platform that tracks millions of companies worldwide, providing insights on funding rounds, valuations, business models, and emerging trends. Its proprietary dataset and AI-driven predictive analytics are used by leading venture capital firms, corporates, and government policymakers to source deals and make data-driven decisions. The company differentiates itself through direct partnerships with more than 100 global tech ecosystems, enabling richer, hard-to-find data and real-time benchmarking. Revenues or user counts were not disclosed, but the platform is positioned as a primary source of record for innovation data. With fresh capital, Dealroom plans to deepen its data assets, enhance AI-powered intelligence tools, and expand product capabilities. International growth is a key focus, beginning with an expanded U.S. presence and the build-out of a team in Lisbon to serve the Portuguese ecosystem. Ultimately, the firm aims to map the world’s tech ecosystems with greater depth, accuracy, and impact.

Led · Series B · Jan 2026

Nagro focuses on improving credit decisions for small and medium-sized rural producers and the broader agribusiness supply chain in Brazil. Its core offering combines direct credit origination with AgRisk, a data and AI-powered platform that delivers credit analysis, governance, and continuous risk monitoring to agribusiness companies and financial institutions. Together, Nagro and AgRisk have processed more than 3 million credit analyses, evaluated over 1 million agricultural CPFs and CNPJs, and serve upwards of 1,400 companies. This extensive data infrastructure underpins more predictable lending in a market prone to climatic and operational volatility. With the new funding, the company plans to enhance its data products, deepen predictive models, and strengthen its technology and governance infrastructure. The leadership believes that combining capital with data intelligence and ongoing monitoring is critical for the next phase of agricultural credit. Financial performance metrics such as revenue were not disclosed in the article.

Participated · Equity · Jan 2026

Blue Health Intelligence is a preventive-care startup that provides a 360° health check in a single 60-minute session, during which hundreds of biometric and lab datapoints are collected and immediately reviewed with a physician. The service, priced at €299 per visit, screens for risks such as cardiovascular disease and diabetes through blood, urine and ultrasound analyses before delivering a personalized action plan. Its first physical clinic will open on Amsterdam’s Prinsengracht in March 2026, and the company plans to roll out additional Dutch locations in the coming years. Founded by former Swapfiets CCO Onno Huyghe, Amberscript co-founder Peter-Paul de Leeuw, and physician-entrepreneur Leanne Verdonck, the venture targets consumers seeking earlier insight into health risks to prevent or delay disease onset. Blue Health Intelligence collaborates with Professor Lee Smith of Anglia Ruskin University to measure long-term outcomes and validate its preventive model. The company positions itself within a broader shift toward privately funded preventive care that could ease pressure on public health systems. Proceeds from its recent funding round will finance the Amsterdam launch and support subsequent expansion and research.